Scientific Programme – Themes
- Bio-engineering, stem cells and disease models
- Models, biomarkers and assays for endocrine disruption
- Models, biomarkers and assays for systemic and immune toxicity
- Models, biomarkers and assays for developmental toxicity
- Cardiotoxicity and cardiac efficacy models
- Local toxicity testing (safety and efficacy)
- Case studies for successful use and implementation of complex in vitro models
- Challenges in cosmetics safety
- Organ-on-a-chip & Microphysiological Systems
- Regulatory considerations for complex NAMs
- Computational toxicology – in silico modelling, read-across, artificial intelligence and machine learning
- Toxicokinetics and in vitro – in vivo extrapolation
- In vitro systems to assess respiratory toxicity
- Non-animal methods for safety testing of biopharmaceuticals/biotherapies/vaccines
- Knowledge sharing and education
- Funding the development, validation and implementation of NAMs
- ECHA, EMA and EFSA perspectives on the use of NAMs
- In vitro and in silico methods for safety assessment of medical devices
- Role of 3R centres in the dissemination and implementation of NAMs
- Other